In 2012, the FDA issued a partial recall of Zofran. Specifically, it recalled the 32 mg intravenous version. It did so because taking this form of the medication could increase the risk of QT interval prolongation, which is an irregular heartbeat that can have fatal implications. However, it did not recall the oral versions of Zofran or the smaller, .15mg intravenous version of Zofran. Interestingly, the FDA acknowledged that the 32 mg intravenous form of Zofran would not be completely taken out of the market until early 2013 due to distribution cycles. Also, it encouraged doctors and patients to report side effects related to Zofran to them.
For additional information see the following pages:
- Why were pregnant women prescribed Zofran?
- What types of birth defects in children have been associated with Zofran usage?
- Has the FDA issued any warnings concerning the use of Zofran during pregnancy?
- Have there been any lawsuits filed against the manufacturer of Zofran related to birth defects in children?
- If I took Zofran during my pregnancy and my child was born with birth defects, can I file a legal claim or lawsuit to recover compensation for their injuries?
- Are there any time constraints for pursuing a lawsuit related to Zofran-birth-defects?
- What must be alleged in a Zofran lawsuit in Federal Court?
- What damages are available for myself and my child in a Zofran birth defect lawsuit?
- If a took a generic version of Zofran, can I still pursue a legal claim for damages related to my child’s birth defects?
- Are there any class action lawsuits against GlaxoSmithKline, the manufacturer of Zofran, for children who have birth defects following Zofran usage during pregnancy?